# Juniper

> Juniper is a San Diego deep-tech venture firm writing first checks into companies using biology, engineering, and computation to remake industry - chemicals, materials, food, mining, and data storage. Co-founded by Cambridge-trained enzyme engineer Jennifer Kan and climate investor Michael Luciani, it spun out of Climate Capital in December 2024 with an oversubscribed ~$10.6M Fund I and a thesis that engineered biology, not another battery, is the missing tool for hard-to-decarbonize sectors.

- **Founded:** 2024
- **Headquarters:** San Diego, California, United States
- **Founders:** Jennifer Kan (General Partner & Co-Founder), Michael Luciani (Founding Partner & Co-Founder)
- **Team size:** Small core team (~3-6); firm says its team doubled in 2025 (public data ranges from 2-10 up to a listed 35)
- **Products:** Fund I, First-check + technical support, Scout program, Community & research
- **Notable:** Spun out of Climate Capital and launched Fund I (oversubscribed, ~$10.6M) in December 2024, covered by TechCrunch., Built a ~27-company portfolio spanning chemicals, materials, food, mining, biocomputing, and conservation - including Colossal (de-extinction) and Cache DNA (DNA data storage)., Jennifer Kan's enzyme-engineering work at Caltech was highlighted in Frances Arnold's 2018 Nobel Prize lecture.

## Products & services

- **Fund I** — Oversubscribed ~$10.6M early-stage fund investing pre-seed and seed checks (roughly $100K-$500K) into bioindustrial startups, with the ability to lead rounds.
- **First-check + technical support** — Hands-on help for scientist-founders: IP strategy, supply-chain partnerships, techno-economic analysis, and navigating the lab-to-market 'valley of death.'
- **Scout program** — A scout network sourcing early bioindustrial founders across synthetic biology, biomanufacturing, and deep tech.
- **Community & research** — Bio-Industrials Happy Hour events and a Substack publishing essays on category creation, ethics, and AI in biology.

## Achievements

- Spun out of Climate Capital and launched Fund I (oversubscribed, ~$10.6M) in December 2024, covered by TechCrunch.
- Built a ~27-company portfolio spanning chemicals, materials, food, mining, biocomputing, and conservation - including Colossal (de-extinction) and Cache DNA (DNA data storage).
- Jennifer Kan's enzyme-engineering work at Caltech was highlighted in Frances Arnold's 2018 Nobel Prize lecture.
- In 2025, portfolio companies collectively raised roughly $77M in venture capital and $46M in grants.
- Jennifer Kan named by Forbes among VCs shaping the future of synthetic biology.

## Latest updates

- **2024-12** — Juniper spins out of Climate Capital and launches its ~$10.6M Fund I to invest in synthetic biology for industry.
- **2025-01** — Team doubles; firm makes roughly seven new investments across the year.
- **2025-11** — Jennifer Kan featured on the 'Going Direct' podcast discussing the future of biomanufacturing and why scientist-founders underuse techno-economic analysis.

## Links

- Website: https://junipervc.com
- LinkedIn: https://www.linkedin.com/company/juniper-vc

---

Profile page: https://yespress.io/juniper
Published by YesPress — https://yespress.io
Last updated: 2026-08-16